€1 in, €5.67 out: How spending on medicines pays back in Europe’s health and economic future
Europe’s spending on innovative medicines buys more than health. A new report shows that every euro returns more than five times in economic value. Newer treatments help people live longer, stay in…
Read the full articleYou might also wanna read
U.S. Healthcare Spending Just Hit $5.7 Trillion and Continues to Grow: 2 Stocks to Buy to Profit From the Trend
Good medical care will always be in high demand, which makes some healthcare stocks strong long-term picks.
MedTech and Healthcare Investments: Opportunities, Risks, and Examples
From diagnosis to therapy: how investments are transforming the medical and healthcare industry and strengthening portfolios How do investme
'Can't treat our way out': Why Australia's $271 billion health spend could miss the mark
A major new report reveals we now live longer, but rising out-of-pocket costs and chronic disease are straining the system.
Five EU countries seek unified response to US and pharma pressure on drug pricing
The U.S. and pharma companies are increasing the pressure on EU countries to pay more for medicines.
politico.eu·29d ago
Portugal's Healthcare Crisis: €1.4 Billion Bailout Raises Questions About System Sustainability
Portugal transfers €1.43B to SNS hospitals in 2026 to clear supplier debts. What the bailout means for public healthcare wait times and serv
Novo Nordisk: Vægttabsmedicin rykker ind i forbrugersegmentet og kan nå 100 mia. dollars i 2030
Vægttabsmedicin har bevæget sig ind i et forbrugersegment. Det giver ifølge markedsanalytikere Novo Nordisk nye vækstmuligheder. I Novo pege
finans.dk·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.